Liver disease (hepatitis, cirrhosis) Board decisions

The Board found no evidence of chronic hepatitis or malaria during service, and the veteran does not have current disabilities related to these conditions. The claim for service connection for hepatitis and malaria is denied.

The Board denied the veteran's claim for service connection for Hepatitis C as there was no evidence of exposure or diagnosis during service, and current medical records do not link the condition to service.

The VA denied the veteran's claim of entitlement to service connection for hepatitis, concluding that there is no evidence of chronic hepatitis or residual disability from past episodes of hepatitis incurred in service.

The Board has determined that the veteran does not currently have hepatitis and there is no evidence of a current disability resulting from an injury suffered or disease contracted in line of duty. The claim for service connection for hepatitis is denied.

The Board has determined that the veteran's asthma does not warrant a rating in excess of 30 percent, and his hepatitis is healed with no current symptoms or residuals. Therefore, both conditions have been denied.

The Board found that the veteran's athlete's foot and blood disorder (including hepatitis) were not incurred or aggravated by active service, nor may they be presumed to be related to service as a result of exposure to Agent Orange. The claims for these conditions are therefore denied.

The Board has determined that hepatitis C with early cirrhosis is related to service and granted the claim.

The Board denied service connection for prostatic hypertrophy and hepatitis. The denial was based on the lack of evidence linking these conditions to active military service.

The Board found no evidence of a current liver disorder or any chronic liver disease during active service, and denied the veteran's claim for service connection.

The Board has granted an increased rating to 60 percent for the veteran's service-connected residuals of abdominal trauma, status post small intestine repair and bowel resection, lysis of adhesions with temporary colostomy, cholecystectomy, and chronic hepatitis C.

The veteran's claim for compensation under 38 U.S.C.A. § 1151 for chronic hepatitis, claimed as secondary to medication prescribed by the VA, was denied because his hepatitis C is not shown to be causally or etiologically related to VA-prescribed medication.

The Board granted a 60 percent disability evaluation for post-hepatic cirrhosis and chronic active hepatitis C, effective January 18, 1994. The veteran's claim was reopened on new evidence submitted in July 23, 1993.

The veteran's hepatitis C is found to be proximately due to or the result of surgeries for his service-connected right knee condition, and thus secondary service connection is granted.

The Board found that the cause of death, hepatic renal syndrome due to or as a consequence of liver cirrhosis and alcoholic hepatitis, was not caused by or contributed substantially or materially to the veteran's death. The service-connected conditions (hepatitis homologous and bronchiectasis) did not play a role in his death.

The Board found that the veteran's hepatitis C was not incurred during service and denied his claim for service connection.

The Board has determined that new and material evidence has been submitted to reopen the veteran's previously denied claim for service connection for hepatitis.

The veteran's claims for hepatitis C and a psychiatric disorder are being remanded to the RO for further adjudication, including scheduling of a personal hearing before a Member of the Board.

The Board has denied the veteran's claims for a compensable rating for his service-connected subacute serum hepatitis with enlargement of the liver and TDIU, finding that compensation is prohibited due to the veteran's own willful misconduct in using drugs.

The Board has remanded this case to re-adjudicate the service connection issue, including whether Hepatitis B is the result of the veteran's own willful misconduct. The claim for a permanent and total disability rating for pension purposes remains in abeyance.

The Board has granted a 60 percent evaluation for hepatitis with cirrhosis of the liver, splenomegaly, and hepatic encephalopathy since July 19, 1997. The current rating is based on recurrent epigastric pain, moderately-elevated liver function tests, splenomegaly, and hepatic encephalopathy with occasional confusion, poor balance, and memory loss.